RetaMaps

Retatrutide in District of Columbia: status and local weight-loss providers

Retatrutide isn't available in District of Columbia yet — it is investigational and not FDA-approved. RetaMaps tracks 27 practice locations here that treat weight and metabolic health; some prescribe FDA-approved GLP-1s today.

Phase 3 complete · Not FDA-approvedRetatrutide: Phase 3 complete · FDA submission planned Q1 2027 · Not available outside trials / expanded access. Tracker

Cities in District of Columbia

Providers in District of Columbia

Rachna Goyal, MD

110 IRVING ST NW, DEPARTMENT OF ENDOCRINOLOGY · Washington, DC 20010

4.6(45 Google reviews · 17 in past year)

TelehealthAccepts insuranceCash pay
Listing updated Oct 2, 2026

Learn about retatrutide

Get retatrutide availability updates for District of Columbia